Search - tctmd.com

Displaying 281 - 300 of 496

Sort: Relevancy | Date

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Innovative FDA Approaches to Future Clinical Research: Proposal for a Cardiac Device Coordinated Research Network (CDCRN)

Presenter: Michael J. Mack, John C Laschinger

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-making?

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Linda D. Gillam

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Embedding "Shared Decision-making" as a Fundamental Component of Clinical Research, Regulatory Device Approval, and Clinical Practice

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Megan Coylewright

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Perspectives on the Hierarchy of Valve Centers of Excellence in the US

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Brian R Lindman

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Perspectives From the NEW Multisociety (AATS, ACCF, SCAI, and STS) Expert Consensus Statement on TAVR Operator and Institutional Requirements

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Carl L. Tommaso

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Stephan Windecker

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Surveying the Present and Future Landscape of AVR Therapy: A Patient-Centered Focus

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Measuring the Patient's Perspective: Quality of Life After TAVR

Presenter: Sandra Lauck

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The Underdiagnosis of Aortic Stenosis: A Novel Approach Using Machine Learning to Improve Acquisition and Interpretation of Echocardiograms

Presenter: Randolph P. Martin, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pi-Cardia Leaflex Aortic Valve Remodeling: Experimental Findings and Early Human Experiences

Presenter: Tamim Nazif, Steven J. Yakubov, Darren Mylotte

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis

Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Shockwave Aortic Valve Remodeling: Experimental Findings and Future Clinical Applications

Presenter: Tamim Nazif, Steven J. Yakubov, Eberhard Grube

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pilot Programs to Address Reduced TAVR Access in Underserved Populations and Communities

Presenter: Randolph P. Martin, Mark J. Russo, Aaron Horne, Jr.

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

Presenter: Howard C. Herrmann, Fabian Nietlispach, Cenap Undemir, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

New Applications for the V8 Valvuloplasty Balloon

Presenter: Tamim Nazif, Steven J. Yakubov, Wesley R. Pedersen

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

Presenter: Lars Sondergaard

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Exploring the Volume-Outcome Relationship With TAVR: Influences of New Devices and Crowd Learning

Presenter: Randolph P. Martin, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

UK All-Comers

Presenter: Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The "Family" of TRUE Balloons: Design Characteristics and Clinical Applications

Presenter: Tamim Nazif, Steven J. Yakubov, Susheel K. Kodali

June 21, 2018

Advertisement

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Innovative FDA Approaches to Future Clinical Research: Proposal for a Cardiac Device Coordinated Research Network (CDCRN)

Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-making?

Embedding "Shared Decision-making" as a Fundamental Component of Clinical Research, Regulatory Device Approval, and Clinical Practice

Perspectives on the Hierarchy of Valve Centers of Excellence in the US

Perspectives From the NEW Multisociety (AATS, ACCF, SCAI, and STS) Expert Consensus Statement on TAVR Operator and Institutional Requirements

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Surveying the Present and Future Landscape of AVR Therapy: A Patient-Centered Focus

Measuring the Patient's Perspective: Quality of Life After TAVR

The Underdiagnosis of Aortic Stenosis: A Novel Approach Using Machine Learning to Improve Acquisition and Interpretation of Echocardiograms

Pi-Cardia Leaflex Aortic Valve Remodeling: Experimental Findings and Early Human Experiences

Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis

Shockwave Aortic Valve Remodeling: Experimental Findings and Future Clinical Applications

Pilot Programs to Address Reduced TAVR Access in Underserved Populations and Communities

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

New Applications for the V8 Valvuloplasty Balloon

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

Exploring the Volume-Outcome Relationship With TAVR: Influences of New Devices and Crowd Learning

UK All-Comers

The "Family" of TRUE Balloons: Design Characteristics and Clinical Applications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content